124 related articles for article (PubMed ID: 23595810)
1. Randomized codon mutagenesis reveals that the HIV Rev arginine-rich motif is robust to substitutions and that double substitution of two critical residues alters specificity.
Possik EJ; Bou Sleiman MS; Ghattas IR; Smith CA
J Mol Recognit; 2013 Jun; 26(6):286-96. PubMed ID: 23595810
[TBL] [Abstract][Full Text] [Related]
2. Diverse mutants of HIV RRE IIB recognize wild-type Rev ARM or Rev ARM R35G-N40V.
Abdallah EY; Smith CA
J Mol Recognit; 2015 Dec; 28(12):710-21. PubMed ID: 26130028
[TBL] [Abstract][Full Text] [Related]
3. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
[TBL] [Abstract][Full Text] [Related]
4. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
Sugaya M; Nishino N; Katoh A; Harada K
J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
[TBL] [Abstract][Full Text] [Related]
5. Thermodynamics of Rev-RNA interactions in HIV-1 Rev-RRE assembly.
Jayaraman B; Mavor D; Gross JD; Frankel AD
Biochemistry; 2015 Oct; 54(42):6545-54. PubMed ID: 26422686
[TBL] [Abstract][Full Text] [Related]
6. Cooperative dimerization of a stably folded protein directed by a flexible RNA in the assembly of the HIV Rev dimer-RRE stem II complex.
Tanamura S; Terakado H; Harada K
J Mol Recognit; 2016 May; 29(5):199-209. PubMed ID: 26620599
[TBL] [Abstract][Full Text] [Related]
7. Altered-specificity mutants of the HIV Rev arginine-rich motif-RRE IIB interaction.
Raad NG; Ghattas IR; Amano R; Watanabe N; Sakamoto T; Smith CA
J Mol Recognit; 2020 Jun; 33(6):e2833. PubMed ID: 31923334
[TBL] [Abstract][Full Text] [Related]
8. Water, shape recognition, salt bridges, and cation-pi interactions differentiate peptide recognition of the HIV rev-responsive element.
Michael LA; Chenault JA; Miller BR; Knolhoff AM; Nagan MC
J Mol Biol; 2009 Sep; 392(3):774-86. PubMed ID: 19631217
[TBL] [Abstract][Full Text] [Related]
9. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
Nam YS; Petrovic A; Jeong KS; Venkatesan S
J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
[TBL] [Abstract][Full Text] [Related]
10. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.
Daly TJ; Doten RC; Rusche JR; Auer M
J Mol Biol; 1995 Oct; 253(2):243-58. PubMed ID: 7563086
[TBL] [Abstract][Full Text] [Related]
11. Proflavine acts as a Rev inhibitor by targeting the high-affinity Rev binding site of the Rev responsive element of HIV-1.
DeJong ES; Chang CE; Gilson MK; Marino JP
Biochemistry; 2003 Jul; 42(26):8035-46. PubMed ID: 12834355
[TBL] [Abstract][Full Text] [Related]
12. Peptide-triggered conformational switch in HIV-1 RRE RNA complexes.
Gosser Y; Hermann T; Majumdar A; Hu W; Frederick R; Jiang F; Xu W; Patel DJ
Nat Struct Biol; 2001 Feb; 8(2):146-50. PubMed ID: 11175904
[TBL] [Abstract][Full Text] [Related]
13. An isostructural G-G to A-A substitution within the HIV RRE RNA switches the specificity towards arginine-rich peptides.
Aoyama S; Sugaya M; Kobayashi C; Masuda K; Maeda T; Sakamoto T; Kawai G; Katoh A; Harada K
Nucleic Acids Symp Ser (Oxf); 2009; (53):271-2. PubMed ID: 19749365
[TBL] [Abstract][Full Text] [Related]
14. Structure of the HIV-1 Rev response element alone and in complex with regulator of virion (Rev) studied by atomic force microscopy.
Pallesen J; Dong M; Besenbacher F; Kjems J
FEBS J; 2009 Aug; 276(15):4223-32. PubMed ID: 19583776
[TBL] [Abstract][Full Text] [Related]
15. Molding a peptide into an RNA site by in vivo peptide evolution.
Harada K; Martin SS; Tan R; Frankel AD
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11887-92. PubMed ID: 9342332
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
Luedtke NW; Tor Y
Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
[TBL] [Abstract][Full Text] [Related]
17. The arginine-rich RNA-binding motif of HIV-1 Rev is intrinsically disordered and folds upon RRE binding.
Casu F; Duggan BM; Hennig M
Biophys J; 2013 Aug; 105(4):1004-17. PubMed ID: 23972852
[TBL] [Abstract][Full Text] [Related]
18. Stereospecificity of short Rev-derived peptide interactions with RRE IIB RNA.
Litovchick A; Rando RR
RNA; 2003 Aug; 9(8):937-48. PubMed ID: 12869705
[TBL] [Abstract][Full Text] [Related]
19. A dynamic in vivo view of the HIV-I Rev-RRE interaction.
Charpentier B; Stutz F; Rosbash M
J Mol Biol; 1997 Mar; 266(5):950-62. PubMed ID: 9086273
[TBL] [Abstract][Full Text] [Related]
20. Retention of conformational flexibility in HIV-1 Rev-RNA complexes.
Wilkinson TA; Zhu L; Hu W; Chen Y
Biochemistry; 2004 Dec; 43(51):16153-60. PubMed ID: 15610009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
